Evidence map›Paper›PMID 35869049›Full record

ArticleCell death discovery2022

BclX

Olivia J Marola, Sarah E R Yablonski, Peter G Shrager, Robert W Nickells, Richard T Libby

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Olivia J MarolaDepartment of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, USA.
Sarah E R YablonskiDepartment of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, USA.
Peter G ShragerDepartment of Neuroscience, University of Rochester, Rochester, NY, USA.
Robert W NickellsDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, WI, USA.ORCID http://orcid.org/0000-0002-2998-5494
Richard T LibbyDepartment of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, USA. richard_libby@urmc.rochester.edu.ORCID http://orcid.org/0000-0003-2844-7632

Funding

UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ROBERT W NICKELLS · 2005 to 2026
$12.6M
VISUAL SCIENCET32EY007125 · NEI · UNIVERSITY OF ROCHESTER · PI Krystel R Huxlin, Duje Tadin · 1990 to 2026
$7.1M
Cell Death Pathways in Glaucomatous NeurodegenerationR01EY018606 · NEI · UNIVERSITY OF ROCHESTER · PI JOHN, SIMON W, LIBBY, RICHARD T · 2008 to 2023
$5.8M
Cell specific roles of the endothelin system in glaucoma-relevant retinal ganglion cell deathR01EY027701 · NEI · UNIVERSITY OF ROCHESTER · PI HOWELL, GARETH R, LIBBY, RICHARD T · 2017 to 2021
$2.7M
Targeting BAX as a Therapeutic for Protection of Retinal Ganglion CellsR01EY030123 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI NICKELLS, ROBERT W · 2019 to 2022
$1.9M
Endothelin Signaling in Glaucomatous NeurodegenerationF31EY030739 · NEI · UNIVERSITY OF ROCHESTER · PI MAROLA, OLIVIA JOYCE · 2020 to 2021
$85k
NEI NIH HHS F31 EY030739NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY018606NEI NIH HHS R01 EY030123NEI NIH HHS T32 EY007125
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35869049
PMCPMC9307748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.